4 Biotechs Targeting Fibrosis Seeking Alpha Lastly, the company plans to file an IND for the prevention of renal transplant rejection by the end of 2012. Risk Factors - For a small, speculative biotech that trades over the counter, there are many real risk factors that investors should consider ... |
